Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperuricaemia
ADR ID BADD_A02167
ADR Hierarchy
14      Metabolism and nutrition disorders
14.09      Purine and pyrimidine metabolism disorders
14.09.01      Disorders of purine metabolism
14.09.01.003      Hyperuricaemia
Description Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. [MeSH]
MedDRA Code 10020903
MeSH ID D033461
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperuricaemia | Hyperuricaemic | Hyperuricemia
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01444Metolazone--
BADD_D01480Mitoxantrone--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.002895%
BADD_D01511Nabumetone--
BADD_D01533Naproxen--
BADD_D01549Nelarabine--
BADD_D01550Nelfinavir mesylate--
BADD_D01558Nexium--
BADD_D01563Nicotinate--
BADD_D01567Nilotinib0.001598%
BADD_D01582Nizatidine--
BADD_D01599Olanzapine--
BADD_D01602Olmesartan--
BADD_D01603Olmesartan medoxomil--
BADD_D01623Oritavancin--
BADD_D01653Paclitaxel0.000533%
BADD_D01667Panobinostat lactate--
BADD_D01668Pantoprazole--
BADD_D01687Pazopanib0.000533%
BADD_D01696Peginterferon alfa-2b--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01784Piroxicam0.006450%
BADD_D01786Pixantrone--
BADD_D01797Polythiazide--
BADD_D01799Ponatinib--
BADD_D01804Posaconazole--
BADD_D01817Pramipexole--
The 5th Page    First    Pre   5 6 7    Next   Last    Total 7 Pages